SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010405
Filing Date
2021-08-05
Accepted
2021-08-05 08:01:38
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1894915
2 EX-31.1 tmb-20210630xex31d1.htm EX-31.1 10809
3 EX-32.1 tmb-20210630xex32d1.htm EX-32.1 6002
4 GRAPHIC tmb-20210630x10q001.jpg GRAPHIC 89333
  Complete submission text file 0001558370-21-010405.txt   6443215

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20210630.xsd EX-101.SCH 42371
6 EX-101.CAL tmb-20210630_cal.xml EX-101.CAL 38000
7 EX-101.DEF tmb-20210630_def.xml EX-101.DEF 128871
8 EX-101.LAB tmb-20210630_lab.xml EX-101.LAB 399198
9 EX-101.PRE tmb-20210630_pre.xml EX-101.PRE 275453
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 1029345
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 211146402
SIC: 2836 Biological Products, (No Diagnostic Substances)